|
Neubauer, A; Greenberg, P; Negrin, R et al. (1994) Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes. Leukemia 8:638-41
|
|
Greenberg, P L (1992) In vitro marrow culture studies in the myelodysplastic syndromes. Semin Oncol 19:34-46
|
|
Lewinsohn, D M; Nagler, A; Ginzton, N et al. (1990) Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 75:589-95
|
|
Greenberg, P; Negrin, R; Nagler, A et al. (1990) Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. Prog Clin Biol Res 338:151-61
|
|
Negrin, R S; Haeuber, D H; Nagler, A et al. (1990) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 76:36-43
|
|
Oksenberg, D; Dieckmann, B S; Greenberg, P L (1990) Functional interactions between colony-stimulating factors and the insulin family hormones for human myeloid leukemic cells. Cancer Res 50:6471-7
|
|
Greenberg, P L; Negrin, R; Nagler, A (1990) Effects of CSFs in preleukemia. Bone Marrow Transplant 6 Suppl 1:121-6
|
|
Nagler, A; Ginzton, N; Negrin, R et al. (1990) Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes. Leukemia 4:193-202
|
|
Greenberg, P; Negrin, R; Nagler, A et al. (1990) Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. Int J Cell Cloning 8 Suppl 1:293-300;discussion 300-2
|
|
Greenberg, P L; Negrin, R; Nagler, A (1990) The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes. Cancer Surv 9:199-212
|
Showing the most recent 10 out of 20 publications
